4:02 AM
 | 
Dec 17, 2018
 |  BC Extra  |  Company News

Proteomics company Seer launches with $36M

Counting nanoparticle pioneer Omid Farokhzad, Robert Langer and Biogen Inc. (NASDAQ:BIIB) vet Philip Ma among its founders, proteomic data company Seer Inc. (South San Francisco, Calif.) launched Monday to develop liquid biopsy tests for early detection of multiple cancers and neurological diseases.

The company believes its nanosensor-based Proteograph platform could enable proteomics to catch up to genomics in scale and speed for routine testing of large populations.

Farokhzad told BioCentury the company aims to develop its own liquid biopsy products in the near term, but believes its platform...

Read the full 419 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >